Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 61, Issue 15, Pages 6629-6646Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.8b00257
Keywords
-
Categories
Funding
- National Natural Science Foundation of China [81673286, 81330077]
- Guangdong Provincial Science and Technology Development Special Foundation [2016A020217006]
- Natural Science Foundation of Guangdong Province [2017A030308003]
Ask authors/readers for more resources
The human proto-oncogene neuroblastoma RAS (NRAS) contains a guanine-rich sequence in the S'-untranslated regions (5'-UTR) of the mRNA that could form an RNA G-quadruplex structure. This structure acts as a repressor for NRAS translation and could be a potential target for anticancer drugs. Our previous studies found an effective scaffold, the quindoline scaffold, for binding and stabilizing the DNA G-quadruplex structures. Here, on the basis of the previous studies and reported RNA-specific probes, a series of novel p-(methylthio)styryl substituted quindoline (MSQ) derivatives were designed, synthesized, and evaluated as NRAS RNA G-quadruplex ligands. Panels of experiments turned out that the introduction of p-(methylthio)styryl side chain could enhance the specific binding to the NRAS RNA G-quadruplex. One of the hits, 4a-10, showed strong stabilizing activity on the G-quadruplex and subsequently repressed NRAS's translation and inhibited tumor cells proliferation. Our finding provided a novel strategy to discover novel NRAS repressors by specifically binding to the RNA G-quadruplex in the 5'-UTR of mRNA.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available